Anika Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon. Thanks again, for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team here at Needham & Company.
Presenting next, we have Anika Therapeutics, Mike -- CFO, Mike Levitz is going to give a presentation and then we're going to hopefully have some time for questions at the end. (Conference Instructions)
So with that, I'll turn it over to Mike.
Great. Thank you, Mike. Hello everybody. I appreciate your time today. I'm excited to walk you through a little bit about what Anika has been up to, where we're going, and why we're excited about the opportunity in front of us. Please reference the Safe Harbor statements and our publicly disclosed documents.
So this is an exciting time for Anika. Anika has been around for over 30 years now, but has a very significant opportunity in front of us and has been in the midst of a meaningful
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
